PQRI is hosting a hybrid workshop – TiO2 Use in Pharmaceuticals – Global Regulatory and Technical Challenges to be held on June 13- 14, 2023 at the Bethesda Marriott (5151 Pooks Hill Road, Bethesda, MD).
The objective of this workshop is to bring together material suppliers, the pharmaceutical industry, and regulatory experts to discuss the impact removing titanium dioxide would have along with the benefits and challenges of the alternatives to titanium dioxide for use in solid oral dosage forms. This workshop will address the following key areas:
The Workshop will be a hybrid event (in-person and virtual). Virtual information will be sent out prior to the start of the Workshop.
Not Available on June 13-14, 2023? No problem. Be sure to register for the Workshop even if you can’t attend it live. All registered Attendees will receive access to On Demand recordings (for 30 days) after the hybrid Workshop has concluded so you can view/review sessions at your convenience. Attending the Workshop IN-PERSON will enable you to get the most out of the experience, but we don’t want you to miss out on the presentations from our excellent speakers.
PLEASE NOTE: Virtual attendees will not have access to the Breakout sessions, only access to the plenary sessions.